Low Back Pain - What's Next? Stratified Care Compared to Current Practice
Launched by REGION OF SOUTHERN DENMARK · Nov 20, 2015
Trial Information
Current as of June 08, 2025
Completed
Keywords
ClinConnect Summary
Methods The study is a two-armed randomized controlled trial in Danish primary health care setting. In total 700 patients are included in the study.
The patients are randomised automatically by a developed database to; 1) Stratified care (treatment matched to stratification according to SBT) or 2) Control treatment (treatment based solely on clinical reasoning).
All data including patient consent is collected and monitored using a web-based data management system.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients found eligible for referral to physiotherapy by the general practitioner (GP)
- • 18 years and above
- • understand Danish language.
- Exclusion Criteria:
- • Serious pathology (malignancy, inflammatory arthritis, etc.),
- • serious nerve root compression (cauda equina, paresis \<3),
- • influential comorbidity, psychiatric illness, personality disorder, spinal surgery during the last 6 months, pregnancy, or already receiving physiotherapy treatment.
About Region Of Southern Denmark
The Region of Southern Denmark is a leading clinical trial sponsor dedicated to advancing medical research and improving patient care through innovative studies. Comprising a network of hospitals and healthcare facilities, the region fosters collaboration among healthcare professionals, researchers, and industry partners to facilitate the development of new therapies and treatments. By prioritizing ethical standards and patient safety, the Region of Southern Denmark aims to contribute significantly to the global medical research landscape while enhancing health outcomes for its diverse population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herning, Central Region, Denmark
Middelfart, Southern Denmark, Denmark
Patients applied
Trial Officials
Lars Morsø, Ph.D
Principal Investigator
Centre for Quality, Institute for Regional Healthresearch
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials